Gelinck, L B S <br/><br/>
Intradermal influenza vaccination in immunocompromized patients is immunogenic and feasible.  [electronic resource] 

 -  Vaccine  Apr 2009 
 - 2469-74 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0264-410X 
<br/><br/><label>Standard No.: </label>10.1016/j.vaccine.2009.02.053  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Viral--blood<br/>Female<br/>HIV Infections--immunology<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Immunocompromised Host<br/>Influenza Vaccines--administration & dosage<br/>Injections, Intradermal<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors<br/>Vaccination